Kazia Therapeutics (KZIA) Assets Average (2009 - 2025)

Kazia Therapeutics has reported Assets Average for 14 years, with the latest figure at $25.3 million in Q4 2025.

• For the quarter ending Q4 2025, Assets Average rose 94.96% year-over-year to $25.3 million; the trailing twelve-month figure through Dec 2025 stood at $25.3 million (up 94.96% YoY), and the FY2025 full-year result was $9.1 million, down 45.13% from the prior year.
• Assets Average for Q4 2025 stood at $25.3 million, up from $7.8 million in the prior quarter.
• The five-year high for Assets Average was $38.6 million in Q4 2021, with the low at $7.8 million in Q2 2025.
• Historically, Assets Average has averaged $22.2 million across 5 years, with a median of $19.9 million in 2022.
• Annual changes were most pronounced in 2021 — Assets Average jumped 153.03% — and 2025, when it sank 48.19%.
• Kazia Therapeutics' Assets Average stood at $38.6 million in 2021, then plunged by 44.77% to $21.3 million in 2022, then declined by 18.82% to $17.3 million in 2023, then dropped by 25.13% to $13.0 million in 2024, then surged by 94.96% to $25.3 million in 2025.
• The last three Assets Average figures came in at $25.3 million (Q4 2025), $7.8 million (Q2 2025), and $13.0 million (Q4 2024), per Business Quant data.